Filter
1351
Featured
111
322
Language
Document type
710
325
166
68
42
19
9
9
3
Countries
103
47
33
25
23
23
23
23
23
22
22
19
17
16
15
15
15
14
13
13
13
13
12
11
11
10
10
10
9
9
9
9
9
8
8
8
8
8
7
7
7
7
6
6
6
6
5
5
5
5
5
5
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
420
106
88
65
61
23
17
1
1
Toolboxes
134
132
90
76
58
49
46
44
39
36
36
30
30
28
26
24
18
17
7
6
6
2
1
1
Рекомендации с позиций общественного здравоохранения
Пересмотренное издание
Программа по ВИЧ/СПИДу
Policy Brief
Technical Brief
ПРактИЧеское РукоВодстВо для соВместных меРоПРИятИй.
Technical Brief
Damon Barrett, Gonçalo Figueiredo Augusto, Martiani Oktavia, Jeanette Olsson, Mira Schneiders and Kate Welch provided background papers and literature reviews which informed this technical series.
Constituting the second part of the World Drug Report 2022, the present booklet contains an overview of the global demand for and supply of drugs.
The first chapter of the booklet begins with the latest estimates of the number of people who use drugs, the distribution of those users by type of drug
...
Constituting the fourth part of the World Drug Report 2022, this booklet focuses on the market dynamics of various stimulants – cocaine, amphetamines and “ecstasy” – and of NPS.
The first chapter contains an analysis of the global market for cocaine, starting with a review of cocaine supply
...
The booklet starts with a general overview of how illicit drugs and the environment are linked within the bigger picture of the Sustainable Development Goals, climate change and environmental sustainability. It highlights direct and indirect linkages and gives examples of the significant local and i
...
19 February 2021
The overall objective of this prospective meta-analyses (PMA) is to estimate the effect of anti-IL-6 therapy compared with usual care in hospitalized patients with suspected or confirmed COVID-19. The primary comparison is of the class effect of anti-IL-6 therapies. It will also es
...
How WHO works to prevent drug use, reduce harm and improve safe access to medicines
Guidance Note
Technical Brief
Accessed: 07.11.2019
16 January 2008
Global Health Advocacy and Activism Department of Global Health, George Washington University
